Maha: ACG to invest Rs 600 crore for Asia's largest capsule plant

The facility in the backward Marathwada region will create 1,000 jobs directly and indirectly by 2023, as per a statement.

It will produce 40 billion capsules annually and will also have a research and development centre adjoining it, it said, adding that pharma and nutraceutical companies domestically and abroad will form the clients.

Officials from ACG signed a memorandum of understanding (MoU) with the Government of Maharashtra for Rs 600 crore investment in the backward Marathwada region of the state, as per the statement.

Read also: Zydus seeks DCGI approval for Desidustat to treat anaemia in kidney patients

The state government has accorded it the status of a 'mega project'.

Our vision to be a future-ready solutions provider to the pharma industry anywhere in the world and our proposed investment of approximately USD 100 million (over Rs 600 crore) in this state-of-the-art plant, is an integral part of ACG's mission to double our capsule manufacturing capacity to 240 billion capsules a year," ACG Managing Director Karan Singh said.